Insider transactions

EDGAR

Vir Biotechnology, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
33 transactions, 1,176,204 shares
Sum of shares × price per share: 8,153,318.8316

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 74

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-15 Filed 2026-11-16Sabatini Brent Officer: SVP, Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)50,0000—111,902Direct (D) Yes
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 25% of the RSUs will vest on November 15, 2027, and the remaining RSUs will vest in three equal annual installments thereafter.
Open filing 0001628280-26-074055 Read from the filing’s XML Dispute this row
2026-11-15 Filed 2026-11-16Sawaf Aziz Officer: EVP, Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)75,0000—75,000Direct (D) Yes
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 25% of the RSUs will vest on November 15, 2027, and the remaining RSUs will vest in three equal annual installments thereafter.
Open filing 0001628280-26-074056 Read from the filing’s XML Dispute this row
2026-11-15 Filed 2026-11-16Sawaf Aziz Officer: EVP, Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (150,000) — exercise price 9.96
Acquired (A)150,0000—150,000Direct (D) Yes
F3
  • F3 25% of the shares subject to the stock option will vest and become exercisable on November 15, 2027, and the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter.
Open filing 0001628280-26-074056 Read from the filing’s XML Dispute this row
2026-11-03 Filed 2026-11-04de Verneuil Vanina Officer: EVP, General Counsel, Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,40711.10
26,717.7

Derived: shares × price per share. Exact value 26717.70.

110,193Direct (D) Yes
F3
  • F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.
Open filing 0001628280-26-070025 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04de Verneuil Vanina Officer: EVP, General Counsel, Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,34311.334
15,221.562

Derived: shares × price per share. Exact value 15221.562.

112,600Direct (D) Yes
F1, F2
  • F1 Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
  • F2 Includes 961 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program.
Open filing 0001628280-26-070025 Read from the filing’s XML Dispute this row
2026-10-27 Filed 2026-10-28Topalian Suzanne Louise Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—8,000Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 1/3 of the RSUs will vest on October 27, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.
Open filing 0001628280-26-067824 Read from the filing’s XML Dispute this row
2026-10-27 Filed 2026-10-28Topalian Suzanne Louise Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,7310—12,731Direct (D) No
F1, F3
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F3 The RSUs will vest in full on the earlier of (i) October 27, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Open filing 0001628280-26-067824 Read from the filing’s XML Dispute this row
2026-10-27 Filed 2026-10-28Topalian Suzanne Louise Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 11.57
Acquired (A)16,0000—16,000Direct (D) No
F4
  • F4 1/3 of the shares subject to the stock option will vest and become exercisable on October 27, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.
Open filing 0001628280-26-067824 Read from the filing’s XML Dispute this row
2026-10-27 Filed 2026-10-28Topalian Suzanne Louise Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (9,462) — exercise price 11.57
Acquired (A)9,4620—25,462Direct (D) No
F5
  • F5 The shares subject to the stock option vest and become exercisable in full on the earlier of (i) October 27, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Open filing 0001628280-26-067824 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12MORE ROBERT J Director
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)8,0000—40,656Direct (D) No
F1
  • F1 Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred by the Reporting Person for no consideration to APNG 1 in connection with the vesting of restricted stock unit (RSU) awards.
Open filing 0001628280-26-056108 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12MORE ROBERT J Director
J

Other acquisition or disposition (describe transaction)

Common Stock
Acquired (A)8,0000—517,917Indirect (I) See footnoteNo
F1, F2
  • F1 Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred by the Reporting Person for no consideration to APNG 1 in connection with the vesting of restricted stock unit (RSU) awards.
  • F2 The shares are held by APNG 1. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG I. As such, the Reporting Person may be deemed to beneficially own the shares held by APNG 1; however, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.
Open filing 0001628280-26-056108 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-10Coughlin Timothy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—8,000Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.
Open filing 0001628280-26-042326 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-10Coughlin Timothy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—16,000Direct (D) No
F1, F3
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F3 The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Open filing 0001628280-26-042326 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-10Coughlin Timothy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 8.51
Acquired (A)16,0000—16,000Direct (D) No
F4
  • F4 1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.
Open filing 0001628280-26-042326 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-10Coughlin Timothy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 8.51
Acquired (A)16,0000—16,000Direct (D) No
F5
  • F5 The shares subject to the stock option vest and become exercisable in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Open filing 0001628280-26-042326 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Sabatini Brent Officer: SVP, Chief Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3799.45
3,581.55

Derived: shares × price per share. Exact value 3581.55.

61,902Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
  • F2 Includes 379 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program.
Open filing 0001628280-26-039938 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Napolitano Janet Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,2009.45
30,240

Derived: shares × price per share. Exact value 30240.00.

21,216Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025.
Open filing 0001628280-26-039943 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28BISCHOFBERGER NORBERT W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—21,333Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 The RSUs will vest in full on May 27, 2027.
Open filing 0001628280-26-038961 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28BISCHOFBERGER NORBERT W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 9.10
Acquired (A)16,0000—16,000Direct (D) No
F4
  • F4 The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Open filing 0001628280-26-038961 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Napolitano Janet Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—24,416Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 The RSUs will vest in full on May 27, 2027.
Open filing 0001628280-26-038965 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Napolitano Janet Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 9.10
Acquired (A)16,0000—16,000Direct (D) No
F3
  • F3 The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Open filing 0001628280-26-038965 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28MORE ROBERT J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—48,656Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 The RSUs will vest in full on May 27, 2027.
Open filing 0001628280-26-038964 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28MORE ROBERT J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 9.10
Acquired (A)16,0000—16,000Direct (D) No
F4
  • F4 The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Open filing 0001628280-26-038964 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Sigal Charles Elliott Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—39,806Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 The RSUs will vest in full on May 27, 2027.
Open filing 0001628280-26-038966 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Sigal Charles Elliott Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 9.10
Acquired (A)16,0000—16,000Direct (D) No
F4
  • F4 The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Open filing 0001628280-26-038966 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Hatfield Jeffrey S. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—39,806Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 The RSUs will vest in full on May 27, 2027.
Open filing 0001628280-26-038963 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Hatfield Jeffrey S. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 9.10
Acquired (A)16,0000—16,000Direct (D) No
F3
  • F3 The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Open filing 0001628280-26-038963 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Farid Ramy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,0000—32,000Direct (D) No
F1, F2
  • F1 Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • F2 The RSUs will vest in full on May 27, 2027.
Open filing 0001628280-26-038962 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-28Farid Ramy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (16,000) — exercise price 9.10
Acquired (A)16,0000—16,000Direct (D) No
F3
  • F3 The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Open filing 0001628280-26-038962 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04SATO VICKI L Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22,00010.0466
221,025.2

Derived: shares × price per share. Exact value 221025.2000.

1,078,391Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open filing 0001628280-26-029640 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-04-30De Backer Marianne Director · Officer: President and CEO
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)233,5320—714,613Direct (D) No
F1
  • F1 Transfer without consideration for tax and estate planning purposes.
Open filing 0001628280-26-029041 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-04-30De Backer Marianne Director · Officer: President and CEO
J

Other acquisition or disposition (describe transaction)

Common Stock
Acquired (A)233,5320—286,650Indirect (I) See FootnoteNo
F1, F2
  • F1 Transfer without consideration for tax and estate planning purposes.
  • F2 The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees.
Open filing 0001628280-26-029041 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-07De Backer Marianne Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)72,5599.156
664,350.204

Derived: shares × price per share. Exact value 664350.204.

948,145Direct (D) Yes
F1
  • F1 Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open filing 0001628280-26-024098 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-02SATO VICKI L Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22,0009.0735
199,617

Derived: shares × price per share. Exact value 199617.0000.

1,100,391Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.87 to $9.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open filing 0001628280-26-022971 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-24Sabatini Brent Officer: SVP, Chief Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,7119.12
70,324.32

Derived: shares × price per share. Exact value 70324.32.

61,902Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
Open filing 0001628280-26-020823 Read from the filing’s XML Dispute this row
2026-03-20 Filed 2026-03-23O'Byrne Jason Officer: EVP Chief Financial Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Disposed (D)2,5000—160,115Direct (D) No
F1
  • F1 Transfer without consideration for estate planning purposes.
Open filing 0001628280-26-020480 Read from the filing’s XML Dispute this row
2026-03-20 Filed 2026-03-23O'Byrne Jason Officer: EVP Chief Financial Officer
J

Other acquisition or disposition (describe transaction)

Common Stock
Acquired (A)2,5000—2,500Indirect (I) See FootnoteNo
F1, F2
  • F1 Transfer without consideration for estate planning purposes.
  • F2 The shares are held in the name of the O'Byrne Family Trust, of which the Reporting Person and his spouse are Trustees.
Open filing 0001628280-26-020480 Read from the filing’s XML Dispute this row
2026-03-02 Filed 2026-03-03SATO VICKI L Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)21,8009.5039
207,185.02

Derived: shares × price per share. Exact value 207185.0200.

1,122,591Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.97 to $9.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open filing 0001628280-26-013630 Read from the filing’s XML Dispute this row
2026-03-02 Filed 2026-03-03SATO VICKI L Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2009.98
1,996

Derived: shares × price per share. Exact value 1996.00.

1,122,391Direct (D) Yes
F1, F3
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.97 to $9.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open filing 0001628280-26-013630 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-26de Verneuil Vanina Officer: EVP, General Counsel, Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)13,7009.82
134,534

Derived: shares × price per share. Exact value 134534.00.

112,982Direct (D) Yes
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2025.
Open filing 0001628280-26-012393 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-26Eisner Mark Officer: EVP and Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,8899.82
18,549.98

Derived: shares × price per share. Exact value 18549.98.

154,024Direct (D) Yes
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.
Open filing 0001628280-26-012394 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26de Verneuil Vanina Officer: EVP, General Counsel, Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,1179.5326
29,713.1142

Derived: shares × price per share. Exact value 29713.1142.

126,682Direct (D) Yes
F1
  • F1 Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open filing 0001628280-26-012393 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26De Backer Marianne Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,7629.5326
140,720.2412

Derived: shares × price per share. Exact value 140720.2412.

1,020,704Direct (D) Yes
F1
  • F1 Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open filing 0001628280-26-012390 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26SATO VICKI L Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)42,3771.485
62,929.845

Derived: shares × price per share. Exact value 62929.845.

1,186,768Direct (D) Yes— Open filing 0001628280-26-012397 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26SATO VICKI L Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)42,1779.7521
411,314.3217

Derived: shares × price per share. Exact value 411314.3217.

1,144,591Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.23 to $10.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open filing 0001628280-26-012397 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26SATO VICKI L Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)20010.26
2,052

Derived: shares × price per share. Exact value 2052.00.

1,144,391Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
Open filing 0001628280-26-012397 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26SATO VICKI L Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (42,377) — exercise price 1.485
Disposed (D)42,3770—0Direct (D) Yes
F3
  • F3 Shares vested and became exercisable in 36 equal monthly installments from October 5, 2017.
Open filing 0001628280-26-012397 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26Eisner Mark Officer: EVP and Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,6169.5326
15,404.6816

Derived: shares × price per share. Exact value 15404.6816.

155,913Direct (D) Yes
F1
  • F1 Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open filing 0001628280-26-012394 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26O'Byrne Jason Officer: EVP Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,6349.5326
15,576.2684

Derived: shares × price per share. Exact value 15576.2684.

162,615Direct (D) Yes
F1
  • F1 Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open filing 0001628280-26-012395 Read from the filing’s XML Dispute this row
2026-02-24 Filed 2026-02-26Sabatini Brent Officer: SVP, Chief Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,4309.5326
13,631.618

Derived: shares × price per share. Exact value 13631.6180.

69,613Direct (D) Yes
F1
  • F1 Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open filing 0001628280-26-012396 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 280

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager22,448,921 SH250,978,938 dollarsHigher by 1,770,638 Prior quarter: 20,678,283Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
ARCH Venture Management, LLC 12,694,163 SH141,920,742 dollarsUnchanged Prior quarter: 12,694,163Open filing 0001012975-26-001080 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 12,024,354 SH134,432,278 dollarsHigher by 529,139 Prior quarter: 11,495,215Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
SB INVESTMENT ADVISERS (UK) LTD Partly reported under another manager10,948,093 SH122,399,680 dollarsUnchanged Prior quarter: 10,948,093Open filing 0001493152-26-052728 Filed 2026-11-17 Dispute this row
GSK plc 8,550,954 SH95,599,666 dollarsUnchanged Prior quarter: 8,550,954Open filing 0001999371-26-024635 Filed 2026-11-05 Dispute this row
STATE STREET CORP Partly reported under another manager7,822,781 SH87,458,692 dollarsLower by 2,141,370 Prior quarter: 9,964,151Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Point72 Asset Management, L.P. 6,772,292 SH75,714,225 dollarsHigher by 1,105,471 Prior quarter: 5,666,821Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 6,449,575 SH72,106,249 dollarsHigher by 60,800 Prior quarter: 6,388,775Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager3,316,968 SH37,076,095 dollarsHigher by 197,547 Prior quarter: 3,119,421Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager3,019,713 SH33,765,816 dollarsLower by 328,653 Prior quarter: 3,348,366Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
MPM BIOIMPACT LLC 2,809,711 SH31,412,569 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-463462 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager2,221,578 SH24,837,242 dollarsHigher by 238,636 Prior quarter: 1,982,942Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
ADAR1 Capital Management, LLC 2,158,839 SH24,135,820 dollarsLower by 297,838 Prior quarter: 2,456,677Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
Saturn V Capital Management LP 2,040,422 SH22,811,918 dollarsHigher by 1,269,779 Prior quarter: 770,643Open filing 0001964437-26-000015 Filed 2026-11-16 Dispute this row
Pictet Asset Management Holding SA 1,904,758 SH21,295,194 dollarsLower by 48,558 Prior quarter: 1,953,316Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row
MORGAN STANLEY Partly reported under another manager1,770,302 SH19,791,982 dollarsLower by 440,775 Prior quarter: 2,211,077Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager1,482,264 SH16,571,711 dollarsHigher by 50,099 Prior quarter: 1,432,165Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,455,978 SH16,277,834 dollarsHigher by 132,793 Prior quarter: 1,323,185Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Hudson Bay Capital Management LP 1,175,000 SH13,136,500 dollarsLower by 189,000 Prior quarter: 1,364,000Open filing 0001393825-26-000083 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 1,133,284 SH12,670,115 dollarsHigher by 23,057 Prior quarter: 1,110,227Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager1,033,561 SH11,555,215 dollarsLower by 108,978 Prior quarter: 1,142,539Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Sio Capital Management, LLC 873,375 SH9,764,333 dollarsLower by 201,899 Prior quarter: 1,075,274Open filing 0001214659-26-014302 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 862,635 SH9,644,259 dollarsHigher by 21,078 Prior quarter: 841,557Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager846,616 SH9,465,167 dollarsLower by 1,518,603 Prior quarter: 2,365,219Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Savvy Advisors, Inc. 837,570 SH9,364,033 dollarsLower by 203,095 Prior quarter: 1,040,665Open filing 0002003633-26-000006 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager834,342 SH8,885,743 dollarsHigher by 31,745 Prior quarter: 802,597Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager818,292 SH9,148,504 dollarsHigher by 469,272 Prior quarter: 349,020Open filing 0000748054-26-000009 Filed 2026-11-20 Dispute this row
GordonMD Global Investments LP 803,552 SH8,983,711 dollarsLower by 550,000 Prior quarter: 1,353,552Open filing 0000919574-26-007964 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager731,594 SH8,179,222 dollarsHigher by 37,220 Prior quarter: 694,374Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
FMR LLC Partly reported under another manager640,200 SH7,157,437 dollarsLower by 1,678,094 Prior quarter: 2,318,294Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager638,336 SH7,136,596 dollarsLower by 15,356 Prior quarter: 653,692Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Candriam S.C.A. 615,679 SH6,908,440 dollarsLower by 11,011 Prior quarter: 626,690Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row
Clearstead Advisors, LLC Partly reported under another manager608,201 SH6,799,676 dollarsLower by 33 Prior quarter: 608,234Open filing 0000842775-26-000005 Filed 2026-11-06 Dispute this row
PRINCIPAL FINANCIAL GROUP INC Partly reported under another manager607,025 SH6,786,539 dollarsHigher by 20,127 Prior quarter: 586,898Open filing 0001126328-26-000225 Filed 2026-11-02 Dispute this row
SUPERSTRING CAPITAL MANAGEMENT LP 578,696 SH6,469,821 dollarsLower by 274,989 Prior quarter: 853,685Open filing 0001931118-26-000011 Filed 2026-11-16 Dispute this row
NORDEA INVESTMENT MANAGEMENT AB Partly reported under another manager546,177 SH5,969,715 dollarsLower by 47,599 Prior quarter: 593,776Open filing 0001218210-26-000023 Filed 2026-11-09 Dispute this row
Invesco Ltd. Partly reported under another manager538,961 SH6,025,585 dollarsHigher by 63,416 Prior quarter: 475,545Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Alta Partners Management Company, L.P. 517,917 SH5,790,312 dollarsHigher by 8,000 Prior quarter: 509,917Open filing 0002054419-26-000014 Filed 2026-11-16 Dispute this row
Parkman Healthcare Partners LLC 517,377 SH5,784,275 dollarsHigher by 42,098 Prior quarter: 475,279Open filing 0001420506-26-002809 Filed 2026-11-16 Dispute this row
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Partly reported under another manager500,000 SH5,590,000 dollarsNot in the prior quarter’s filings read Open filing 0000905148-26-004861 Filed 2026-11-16 Dispute this row
Public Sector Pension Investment Board 431,729 SH4,649,721 dollarsHigher by 14,520 Prior quarter: 417,209Open filing 0001396318-26-000039 Filed 2026-11-10 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager402,546 SH4,500,464 dollarsLower by 588,791 Prior quarter: 991,337Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager395,964 SH4,426,878 dollarsLower by 620,900 Prior quarter: 1,016,864Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Ensign Peak Advisors, Inc 390,021 SH4,360,435 dollarsLower by 443,758 Prior quarter: 833,779Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row
PANAGORA ASSET MANAGEMENT INC 370,909 SH4,146,763 dollarsLower by 3,356 Prior quarter: 374,265Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager352,421 SH3,940,067 dollarsLower by 228,995 Prior quarter: 581,416Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
Edgestream Partners, L.P. Partly reported under another manager339,865 SH3,799,691 dollarsHigher by 205,544 Prior quarter: 134,321Open filing 0001535061-26-000005 Filed 2026-11-10 Dispute this row
HRT FINANCIAL LP 334,142 SH3,735 dollarsHigher by 26,038 Prior quarter: 308,104Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
Susquehanna Portfolio Strategies, LLC 332,569 SH3,718,121 dollarsLower by 12,972 Prior quarter: 345,541Open filing 0001996449-26-000009 Filed 2026-11-16 Dispute this row
RHUMBLINE ADVISERS 294,884 SH3,296,782 dollarsHigher by 9,730 Prior quarter: 285,154Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Boxer Capital Management, LLC 1,866,000 SH
  • Sixth Street Partners Management Company, L.P. 1,323,185 SH
  • Jones Hill Capital LP 659,213 SH
  • Weiss Asset Management LP 555,541 SH
  • Avidity Partners Management LP 519,300 SH
  • JACOBS LEVY EQUITY MANAGEMENT, INC 136,335 SH
  • Empyrean Capital Partners, LP 114,000 SH
  • NOMURA HOLDINGS INC 96,100 SH
  • NOMURA HOLDINGS INC 96,100 SH
  • Schonfeld Strategic Advisors LLC 73,914 SH
  • INTECH INVESTMENT MANAGEMENT LLC 68,270 SH
  • ACT CAPITAL MANAGEMENT, LLC 64,300 SH
  • Headlands Technologies LLC 64,299 SH
  • Jupiter Topco LLC 54,789 SH
  • CAISSE DES DEPOTS ET CONSIGNATIONS 50,235 SH
  • Mariner, LLC 29,756 SH
  • Brevan Howard Capital Management LP 21,598 SH
  • E Fund Management Co., Ltd. 19,384 SH
  • Vinva Investment Management Ltd 15,477 SH
  • DRW Securities, LLC 14,108 SH
  • Mach-1 Financial Group, LLC 11,777 SH
  • FIDUCIARY FINANCIAL ADVISORS 2,860 SH
  • Pacer Advisors, Inc. 2,296 SH
  • Twin Lakes Capital Management, LLC 2,195 SH
  • Integrated Wealth Concepts LLC 1,576 SH
  • Optiver Holding B.V. 473 SH
  • BESSEMER GROUP INC 207 SH
  • Quantbot Technologies LP 168 SH
  • Cornerstone Planning Group LLC 100 SH
  • Plante Moran Financial Advisors, LLC 38 SH
  • Evolution Advisers, Inc. 17 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
ARCH Venture Fund IX, L.P. Common Stock, $0.0001 par value6.911,897,98811/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
ARCH Venture Fund IX Overage, L.P. Common Stock, $0.0001 par value6.911,897,98811/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
ARCH Venture Partners IX, L.P. Common Stock, $0.0001 par value6.911,897,98811/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
ARCH Venture Partners IX Overage, L.P. Common Stock, $0.0001 par value6.911,897,98811/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
ARCH Venture Partners IX, LLC Common Stock, $0.0001 par value6.911,897,98811/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
Robert Nelsen Common Stock, $0.0001 par value7.312,508,02911/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
Keith Crandell Common Stock, $0.0001 par value7.112,170,95211/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
Clinton Bybee Common Stock, $0.0001 par value7.011,989,71811/04/2026 Filed 2026-11-06SCHEDULE 13D/AAmendment 8Open filing 0001012975-26-001020 Dispute this row
STATE STREET CORPORATION COMMON STOCK4.67,822,781.0009/30/2026 Filed 2026-11-10SCHEDULE 13GOpen filing 0000093751-26-000742 Dispute this row
BlackRock, Inc. Common Stock12.420,905,68109/30/2026 Filed 2026-10-27SCHEDULE 13G/AAmendment 4Open filing 0002012383-26-003861 Dispute this row
STATE STREET CORPORATION COMMON STOCK5.99,964,151.0006/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000093751-26-000556 Dispute this row
Vanguard Portfolio Management Common Stock6.8511,554,37706/30/2026 Filed 2026-07-31SCHEDULE 13G/AAmendment 1Open filing 0002100121-26-000992 Dispute this row
SB Investment Advisers (UK) Limited Common Stock, $0.0001 par value6.510,948,093.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 4Open filing 0001493152-26-024001 Dispute this row
SoftBank Vision Fund (AIV M1) L.P. Common Stock, $0.0001 par value6.510,948,093.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 4Open filing 0001493152-26-024001 Dispute this row
SVF Endurance (Cayman) Limited Common Stock, $0.0001 par value6.510,948,093.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 4Open filing 0001493152-26-024001 Dispute this row
Vanguard Portfolio Management Common Stock5.799,257,23503/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100121-26-000797 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 3Open filing 0000102909-26-002579 Dispute this row
ARCH Venture Fund IX, L.P. Common Stock, $0.0001 par value8.112,916,66302/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
ARCH Venture Fund IX Overage, L.P. Common Stock, $0.0001 par value8.112,916,66302/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
ARCH Venture Partners IX, L.P. Common Stock, $0.0001 par value8.112,916,66302/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
ARCH Venture Partners IX Overage, L.P. Common Stock, $0.0001 par value8.112,916,66302/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
ARCH Venture Partners IX, LLC Common Stock, $0.0001 par value8.112,916,66302/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
Robert Nelsen Common Stock, $0.0001 par value8.513,534,70402/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
Keith Crandell Common Stock, $0.0001 par value8.313,189,62702/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
Clinton Bybee Common Stock, $0.0001 par value8.113,008,39302/27/2026 Filed 2026-03-03SCHEDULE 13D/AAmendment 7Open filing 0001012975-26-000222 Dispute this row
SB Investment Advisers (UK) Limited Common Stock, $0.0001 par value9.413,116,977.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0001493152-26-007174 Dispute this row
SoftBank Vision Fund (AIV M1) L.P. Common Stock, $0.0001 par value9.413,116,977.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0001493152-26-007174 Dispute this row
SVF Endurance (Cayman) Limited Common Stock, $0.0001 par value9.413,116,977.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0001493152-26-007174 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,536 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,154

Filings made before the SEC required XML are listed, not extracted.

Back to Vir Biotechnology, Inc.